发明名称 |
Combination therapy using an HDAC inhibitor, carboplatin and paclitaxel for treating ovarian cancer |
摘要 |
<p>The present invention pertains to a method for treating cancer, such as lung cancer, multiple myeloma, lymphoma, and epithelial ovarian cancer, comprising the administration to a patient in need thereof a first amount or dose of a histone deacetylase (HDAC) inhibitor, such as PXD-101, and a second amount or dose of carboplatin/paclitaxel, wherein the first and second amounts or doses together comprise a therapeutically effective amount.</p> |
申请公布号 |
EP2522395(A1) |
申请公布日期 |
2012.11.14 |
申请号 |
EP20120156537 |
申请日期 |
2006.02.03 |
申请人 |
TOPOTARGET UK LIMITED |
发明人 |
LICHENSTEIN, HENRI;JEFFERS, MIKE;XIAOZHANG, QIAN;SEHESTED, MAXWELL;PETERSEN, KAMILLE DUMONG;RITCHIE, JAMES |
分类号 |
A61P35/00;A61K31/18;A61K31/337;A61K31/555 |
主分类号 |
A61P35/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|